Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

Diabetes

Volumn 48, Issue 4, 1999, Pages 890-895

  Morange, Pierre Emmanuel ^a   Aubert, Jérome ^c   Peiretti, Franck ^a   Lijnen, H Roger ^d   Vague, Philippe ^b   Verdier, Monique ^a   Négrel, Raymond ^c   Juhan Vague, Irène ^a   Alessi, Marie Christine ^a,e  

^a Laboratoire d' Hematologie   (France)

^b INSERM   (France)

^c CENTRE DE BIOCHIMIE   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; INSULIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOSE TISSUE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS REGULATION; REGULATORY MECHANISM;

EID: 0033000074     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.890     Document Type: Article

References (55)

1. Juhan-Vague I, Alessi MC: Fibrinolysis and risk of coronary artery disease. Fibrinolysis 10:127-136, 1996
2. Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94:2057-2063, 1996
3. Sawdey S, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor (PAI-1) gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor a and transforming growth factor b. J Clin Invest 88:1346-1353, 1991
4. Samad F, Yamamoto K, Loskutoff DJ: Distribution and regulation of plasminogen activator inhibitor 1 in murine adipose tissue in vivo. J Clin Invest 971:37-46, 1996
5. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukada Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803, 1996
6. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G: Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 16:368-374, 1996
7. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P: Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes 22:312-317, 1998
8. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by himan adipose tissue. Diabetes 46:860-867, 1997
9. Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Arner P: Adipose tissue secretion of plasminogen activator inhibitor-1 in non obese individuals. Diabetologia 41:65-71, 1998
10. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D: Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986
11. Juhan-Vague I, Alessi MC, Raccah D, Aillaud MF, Billerey M, Ansaldi J, Philip-Joet C, Vague P: Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-levels. Thromb Haemostas 67:76-82, 1992
12. Karpe F, Bavenholm P, Proudler A, Silveira A, Crook D, Blomback M, de Faire U, Hamsten A: Relationships of insulin and intact or split proinsulin to haemostatic function in young men with and without coronary artery disease. J Int Med 236:75-88, 1994
13. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clarck PMS, Schneider AE, Hales CN, Yudkin JS: The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33:532-537, 1990
14. Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D: Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemostas 60:491-494, 1988
15. Kooistra T, Bosma PJ, Tons HAM, Van Den Berg AP, Meyer P, Princen HMG: Plasminogen activator inhibitor 1: biosynthesis and mRN A level are increased by insulin in cultured human hepatocytes. Thromb Haemostas 62:723-728, 1989
16. Schneider DJ, Sobel BE: Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type 1: implications for vascular disease by hyperinsulinemic states. Proc Natl Acad Sci U S A 88:995-996, 1991
17. Anfosso F, Chomiki N, Alessi MC, Vague P, Juhan-Vague I: Plasminogen activator inhibitor 1 synthesis in the human hepatoma cell line Hep G2: metformin inhibits the stimulating effect of insulin. J Clin Invest 91:2185-2193, 1993
18. Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A: The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coag Fibrinol 3:789-793, 1992
19. Patrassi GM, Sartori MT, Livi U, Casonato A, Danesin C, Vettore S, Girolami A: Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation. Transplantation 64:1610-1614, 1997
20. Partridge CA, Gerritsen ME: Dexamethasone increases the release of three 44 KD proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary microvessel endothelial cells. Thromb Res 57:139-154, 1990
21. Oikarinen A, Hoyhtya M: Dexamethasone-induced plasminogen activator inhibitor: characterization, purification, and preparation of monoclonal antibodies. Arch Dermatol Res 282:153-158, 1990
22. Heaton JH, Kathju S, Gelehter TD: Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides. Mol Endocrinol 6:53-60, 1992
23. Rodbell M: Metabolism of isolated fat cells: effect of hormone on fat metabolism and lipolysis. J Biol Chem 239:375-380, 1964
24. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody, based on enzyme-linked immunoadsorbant assay. Blood 71:220-225, 1988
25. Declerck PJ, Verstreken M, Collen D: Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 74:1305-1309, 1995
26. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
27. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 92:2746-2755, 1993
28. Dani C, Bertrand B, Bardon S, Doglio A, Amri E, Grimaldi P: Regulation of gene expression by insulin in adipose cells: opposite effects on adipsin and glycerophosphate dehydrogenase genes. Mol Cell Endocrinol 63:199-208, 1989
29. Aubert J, Darimont C, Safonova I, Ailhaud G, Négrel R: Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 328:701-700, 1997
30. Santell L, Levin EG: Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor 1 from human endothelial cells. J Biol Chem 263:16802-16808, 1988
31. Slivka SR, Loskutoff DJ: Regulation of type I plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim Biophys Acta 1094:317-322, 1991
32. Bergonzelli GE, Kruithof EKO, Medcalf R: Transcriptional antagonism of phorbol ester-mediated induction of plasminogen activator inhibitor types 1 and 2 by cyclic adenosine 3′5′-monophosphate. Endocrinology 131:1467-1472, 1992
33. Fain JN, Garcia-Sainz JA: Adrenergic regulation of adipocyte metabolism. J Lipid Res 24:945-966, 1983
34. Samad F, Loskutoff DJ: Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 2:5-10, 1998
35. Livingston JN, Lerea KM, Bolinder J, Kager L, Backman L, Arner P: Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity. Diabetologia 27:447-453, 1984
36. Haynes FJ, Helmerhorst E, Yip CC: The structure of the hepatic insulin receptor and insulin binding. Biochem J 239:127-133, 1986
37. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudalial SR, Olefsky J, Caro JF: Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 45:699-701, 1996
38. Nolan JJ, Olefsky JM, Nyce MR, Considine RV, Caro JF : Effect of troglitazone on leptin production studies in vitro and in human subjects. Diabetes 45:1276-1278, 1996
39. Leroy P, Dessolin S, Villageois P, Moon BC, Friedman JM, Ailhaud G, Dani C: Expression of ob gene in adipose cells: regulation by insulin. J Biol Chen 271:2365-21368, 1996.
40. Wabitsch M, Jensen PB, Blum WF, Crristoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H: Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 45:1435-1438, 1996
41. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE: Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994
42. Nordt TK, Sawa H, Fujii S, Sobel BE: Induction of PAI-1 by proinsulin and insulin in vivo. Circulation 91:764-770, 1995
43. Landin K, Tengborn L, Smith U: Effect of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man. Thromb Haemost 71:783-187, 1994
44. Considine RV, Nyce MR, Kolaczynski JW, Zhang PL, Ohannesian JP, Moore JH, Fox JW, Caro JF: Dexamethasone stimulates leptin release from human adipocytes: unexpected inhibition by insulin. J Cell Biochem 65:254-258, 1997
45. Casabiell X, Pineiro V, Peino R, Lage M, Camilla J, Gallego R, Vallejo LG, Dieguez C, Casanueva SS: Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 83:2149-2155, 1998
46. Stern JS, Brown S, Stanhope K, Uriu J, Gastonguay TW, Bray GA: Adrenalectomy reduces weight gain, adipose cell size and lipoprotein lipase activity in obese male Zucker rats. Fed Proc 42:393-394, 1983
47. Hauner H, Entenmann G, Wabitsch M, Gaillard G, Ailhaud G, Négrel R, Pfeiffer E: Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 84:1663-1670, 1989
48. Björntorp P: Endocrine abnormalities of obesity Metabolism 44:21-23, 1995
49. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R, Labate AM, Barbara L: The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 77:341-346, 1993
50. Bujalska IJ, Kumar S, Stewart PM: Does central obesity reflect "Cushing's disease of the omentum"? Lancet 349:1210-1213, 1997
51. Rebuffe-Scrive M, Brönnegard M, Nillson A, Eldh J, Gustafsson J-A, Bjöntorp P: Steroid hormone receptors in human adipose tissue. J Clin Endocrinol Metab 71:1215-1219, 1990
52. Chandler WL, Mornin D, Whitten RO, Angleton P, Farin FM, Fritsche TR, Veith RC, Stratton JR: Insulin, cortisol and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res 58:1-12, 1990
53. Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D: Increased PA-Inhibitor levels in the post operative period: no cause effect relation with increased cortisol. Thromb Haemost 54:466-468, 1985
54. Dunkleman SS, Fairhurst B, Plager J, Waterhouse C: Cortisol metabolism in obesity. J Clin Endocrinol 24:341-346, 1993
55. Williams SK, Wang TF, Castrillo R, Jarrell BE: Liposuction-derived human fat used for vascular graft sodding contains endothelial cells and not mesothelial cells as the major cell type. J Vasc Surg 19:916-923, 1994